UDP-β-L-arabinopyranose

Metabolite details

Identifier

DQQDLYVHOTZLOR-IAZOVDBXSA-N

InChI Key

DQQDLYVHOTZLOR-IAZOVDBXSA-N

IUPAC name

uridine 5'-[3-(β-L-arabinopyranosyl) dihydrogen diphosphate]

Preferred name

UDP-β-L-arabinopyranose

INN name

—

Synonym

uridine 5'-diphospho-β-L-arabinopyranose

ChEBI

CHEBI:61455

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• wild_type_vs_patA_deletion